Acknowledgements
Project funding
Ensembl receives majority funding from Wellcome Trust [222155/Z/20/Z] with additional funding for specific project components including the National Human Genome Research Institute of the National Institutes of Health under award number 2U24HG007234-09, U41HG010972, R01 HG010485, U24HG011451, and 2U24HG007497-05. Ensembl receives further funding from The Biotechnology and Biological Sciences Research Council [BB/W019108/1, BB/P016855/1, BB/T015608/1, BB/T01461X/1]; Open Targets; Wellcome Trust [212925/Z/18/Z, 226458/Z/22/Z, 226083/Z/22/Z]; ELIXIR: the research infrastructure for life-science data, and the European Molecular Biology Laboratory. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 733161 (MultipleMS), No. 825575 (EJP RD), No. 817923 (AQUA-FAANG), No. 817998 (GENE-SWitCH), and No. 815668 (BovReg). This project is funded in part by the Gordon and Betty Moore Foundation through grant CBMF8897.
Funded by Wellcome
Co-funded by the European Union
Previous sources of funding
The Wellcome Trust Sanger Institute was a partner in the Ensembl project until 2016.
EU Framework Programme 6
The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement n° 282510 - BLUEPRINT.
Web image credits
- All animal images on this site are public domain or used with permission of their creators. Please see our image credits page for full details.
- The small icons used in the web interface are derived from the Rocky set by Icon Dock.
- Project logos are used with permission of the relevant organisations